Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.

SB 1170 (2021-2022)

https://ontology.bommaritollc.com/id/01a0d568-2d91-77ae-adc6-85643a526617

adms:identifier	mi-legislature-measure 2021-2022/SB/1170
dcterms:temporal	Michigan Legislature, 2021-2022 session
primary sponsor	Curtis S VanderWall
prov:wasDerivedFrom	evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2022-SB-1170 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2022-SB-1170 evidence from https://www.legislature.mi.gov/Bills/Bill?ObjectName=2022-SB-1170
schema:legislationChanges	MCL 15.677 MCL 15.673
schema:legislationIdentifier	SB 1170
schema:legislationJurisdiction	Michigan
schema:legislationType	bill
schema:name	Health: pharmaceuticals; distribution of naloxone under the administration of opioid antagonist act to any individual; provide for. Amends title & secs. 103 & 107 of 2019 PA 39 (MCL 15.673 & 15.677) & adds sec. 106. TIE BAR WITH: SB 1171'22en
schema:sponsor	Curtis S VanderWall
schema:url	https://www.legislature.mi.gov/Bills/Bill?ObjectName=2022-SB-1170
skos:prefLabel	SB 1170 (2021-2022)en
status	in committee
status date	2022-11-29xsd:date